Please contact us for more information or to learn if you are eligible to participate.
To evaluate the effectiveness of repurposed medications [(study drug(s)] in reducing symptoms of nonhospitalized participants with mild to moderate COVID-19
Carlos A. Paris, MD
National Center for Advancing Translation Sciences
Type of Trial